13F

Stock

Adaptimmune Therapeutics Plc

ADAPY · held by 10 managers

Reported value

$79.7K

Holders

10

+0 new · −3 exited

Holders’ est. mark

−$264

Price effect on 1 books still in the name

Largest holder

$37.8K

JOSH ARNOLD INVESTMENT CONSULTANT, LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
JOSH ARNOLD INVESTMENT CONSULTANT, LLC20K$37.8KHeld
Empirical Finance, LLC800K$20.8KHeld
Rathbones Group PLC432.8K$11.3KHeld
XTX Topco Ltd353.8K$9.2KHeld
SIMPLEX TRADING, LLC18.6K$483Held
RHUMBLINE ADVISERS3.66K$95Held
BARCLAYS PLC2.53K$66−$264Cut−$264
X-Square Capital, LLC11.4K$0Held
ACADIAN ASSET MANAGEMENT LLC17.2K$0Held
TD Waterhouse Canada Inc.14$0Held

Who left

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.